19-14151035-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_014921.5(ADGRL1):āc.4248A>Cā(p.Glu1416Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000159 in 1,255,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014921.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRL1 | NM_014921.5 | c.4248A>C | p.Glu1416Asp | missense_variant | 23/23 | ENST00000361434.8 | NP_055736.2 | |
ADGRL1-AS1 | NR_045214.1 | n.73-4117T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRL1 | ENST00000361434.8 | c.4248A>C | p.Glu1416Asp | missense_variant | 23/23 | 1 | NM_014921.5 | ENSP00000355328 | A1 | |
ADGRL1-AS1 | ENST00000588387.2 | n.79-4117T>G | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000712 AC: 1AN: 140456Hom.: 0 Cov.: 29
GnomAD4 exome AF: 8.97e-7 AC: 1AN: 1115134Hom.: 0 Cov.: 39 AF XY: 0.00 AC XY: 0AN XY: 542818
GnomAD4 genome AF: 0.00000712 AC: 1AN: 140456Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 68096
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.4263A>C (p.E1421D) alteration is located in exon 24 (coding exon 23) of the ADGRL1 gene. This alteration results from a A to C substitution at nucleotide position 4263, causing the glutamic acid (E) at amino acid position 1421 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at